N Mesaros, P Nordmann, P Plesiat, M … - Clinical Microbiology & …, 2007 - nursing2007.com Pseudomonas aeruginosa is a major cause of nosocomial infections. This organism shows a
remarkable capacity to resist antibiotics, either intrinsically (because of constitutive expression
of β-lactamases and efflux pumps, combined with low permeability of the ... Cited by 48 - Related articles - Cached - BL Direct - All 12 versions
SM Rowe, JP Clancy - Current opinion in pediatrics, 2006 - journals.lww.com Purpose of review: Over the past four decades, outcomes for patients with cystic fibrosis have
improved dramatically. Major contributors to this improvement are a better understanding of disease
pathogenesis and the systematic conduct of clinical trials evaluating new therapies ... Cited by 22 - Related articles - BL Direct - All 4 versions
JA Bartlett, AJ Fischer, PB McCray Jr - Trends in Innate Immunity, 2008 - books.google.com Egesten A, Schmidt A, Herwald H (eds): Trends in Innate Immunity. Contrib Microbiol. Basel,
Karger, 2008, vol 15, pp 147-163 Innate Immune Functions of the Airway Epithelium Jennifer
A. Bartlett• Anthony J. Fischer• Paul B. McCray Jr Departments of Pediatrics and ... Cited by 13 - Related articles - All 3 versions
SMK Buckley, SJ Howe, V Sheard, NJ Ward, C … - Gene Therapy, 2008 - nature.com Gene transfer for cystic fibrosis (CF) airway disease has been hampered by the lung's innate
refractivity to pathogen infection. We hypothesized that early intervention with an integrating
gene transfer vector capable of transducing the lung via the lumen may be a successful ... Cited by 9 - Related articles - All 4 versions
GI Parameswaran, TF Murphy - Infectious Disease Clinics of North America, 2007 - Elsevier COPD is a major health problem worldwide. Nearly 7% of the adult United States population
has COPD and it is currently the fourth leading cause of death in United States [1]. COPD is projected
to become the third leading cause of death worldwide by 2020 [2]. In patients with ... Cited by 5 - Related articles - All 40 versions
AF Petit-Bertron, O Tabary, H Corvol, J Jacquot, A … - Cytokine, 2007 - Elsevier We compared blood neutrophils (PMNs) collected from healthy subjects with PMNs derived from
either blood or airways collected from the same cystic fibrosis (CF) patients. When compared
to healthy blood PMNs, CF blood PMNs expressed enhanced level of CD64, a marker of ... Cited by 4 - Related articles - All 2 versions
N Mesaros, P Nordmann, P Plésiat, M Roussel- … - Antibiotiques, 2007 - farm.ucl.ac.be (1) Unité de pharmacologie cellulaire et moléculaire, Université catholique de Louvain
7370, avenue Mounier 73, Bruxelles, Belgique. (2) Hôpital de Bicêtre & Université de Paris
XI, Paris. (3) Centre hospitalo-universitaire Jean Minjoz, & Université de Franche-Comté, ... Cited by 1 - Related articles - View as HTML - BL Direct - All 3 versions
JABAJ Fischer, PB McCray Jr - Contrib Microbiol, 2008 - content.karger.com Abstract The epithelium of the respiratory tract forms a large surface area that maintains intimate
contact with the environment. Through the act of breathing, this mucosal surface encounters
an array of pathogens and toxic particulates. In response to these challenges many ... Related articles - All 2 versions
JP Clancy - jhasim.com The significant strides made in the under- standing of cystic fibrosis (CF) and the availabili- ty
of multiple therapies have dramatically improved patient outcomes, but these advances have
also led to new challenges, particularly in regard to treatment selection for pulmonary ... Related articles
